Understanding Active Surveillance for Prostate Cancer.

Lillian Y LaiVahakn B ShahinianMary K OerlineSamuel R KaufmanTed A SkolarusMegan E V CaramBrent K Hollenbeck

Published in: JCO oncology practice (2021)

Nontrivial percentages of patients on active surveillance are managed by physicians outside of urology. Given the interspecialty variations observed, efforts to strengthen the evidence underlying surveillance pathways and to engage other specialties in guideline development are needed.

Keyphrases

prostate cancer
end stage renal disease
newly diagnosed
ejection fraction
public health
primary care
prognostic factors
quality improvement